2019
Use of big data to identify risk of adverse HIV outcomes
Vermund SH. Use of big data to identify risk of adverse HIV outcomes. The Lancet HIV 2019, 6: e488-e489. PMID: 31303556, PMCID: PMC7784960, DOI: 10.1016/s2352-3018(19)30191-2.Peer-Reviewed Original Research
2018
Impact of HIV on human papilloma virus-mediated cervical disease progression
Vermund SH, Kelley KF. Impact of HIV on human papilloma virus-mediated cervical disease progression. AIDS 2018, 32: 1715-1717. PMID: 30001245, PMCID: PMC7024578, DOI: 10.1097/qad.0000000000001841.Peer-Reviewed Original Research
2014
Current drug use and lack of HIV virologic suppression: point-of-care urine drug screen versus self-report
Qian HZ, Mitchell VJ, Bebawy S, Cassell H, Perez G, McGowan CC, Sterling TR, Vermund SH, D’Aquila R, Hulgan T. Current drug use and lack of HIV virologic suppression: point-of-care urine drug screen versus self-report. BMC Infectious Diseases 2014, 14: 508. PMID: 25234368, PMCID: PMC4175271, DOI: 10.1186/1471-2334-14-508.Peer-Reviewed Original ResearchConceptsUrine drug screensCurrent drug usePositive urine drug screenComputer Assisted Self-InterviewVirologic suppressionDrug useAntiretroviral therapyDrug screensNegative urine drug screensHigher CD4 countsHIV disease progressionRoutine clinic visitsHIV virologic suppressionCross-sectional studyLower self-reported ratesSelf-reported ratesCD4 countClinic visitsPrognostic informationDisease progressionCaucasian raceART usersLower likelihoodResultsAbout halfSelf interview
2013
Impact of Definitions of Loss to Follow-up on Estimates of Retention, Disease Progression, and Mortality: Application to an HIV Program in Mozambique
Shepherd BE, Blevins M, Vaz LM, Moon TD, Kipp AM, José E, Ferreira FG, Vermund SH. Impact of Definitions of Loss to Follow-up on Estimates of Retention, Disease Progression, and Mortality: Application to an HIV Program in Mozambique. American Journal Of Epidemiology 2013, 178: 819-828. PMID: 23785113, PMCID: PMC3755641, DOI: 10.1093/aje/kwt030.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virusVisit scheduleKaplan-Meier techniqueRate of mortalityAntiretroviral therapyCumulative incidenceTreatment initiationEstimates of retentionImmunodeficiency syndromeImmunodeficiency virusHIV programsChronic diseasesDisease progressionPatient retentionImpact of definitionsHIV literatureClinical encountersStudy outcomesMortalityAIDSLTFDeathInformative censoringProgram evaluationStudy conclusions
2008
Impact of small reductions in plasma HIV RNA levels on the risk of heterosexual transmission and disease progression
Modjarrad K, Chamot E, Vermund SH. Impact of small reductions in plasma HIV RNA levels on the risk of heterosexual transmission and disease progression. AIDS 2008, 22: 2179-2185. PMID: 18832881, PMCID: PMC2661869, DOI: 10.1097/qad.0b013e328312c756.Peer-Reviewed Original ResearchMeSH KeywordsAcquired Immunodeficiency SyndromeDisease ProgressionFemaleHeterosexualityHIV InfectionsHIV-1HumansMaleRisk AssessmentRNA, ViralViral LoadConceptsRisk of progressionHeterosexual transmissionDisease progressionHIV RNALog10 incrementAntiretroviral therapyPlasma HIV RNA levelsGreater riskTreatment of coinfectionHIV RNA levelsHIV viral loadViral load changesHIV-1 RNARelative risk estimatesHIV loadAdjunctive careViral loadPlasma levelsHeterosexual contactWorld's HIVAnnual riskHIVAdult populationViral transmissionRisk estimates
2007
A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virus
Stringer EM, Kaseba C, Levy J, Sinkala M, Goldenberg RL, H. B, Matongo I, Vermund SH, Mwanahamuntu M, Stringer JS. A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virus. American Journal Of Obstetrics And Gynecology 2007, 197: 144.e1-144.e8. PMID: 17689627, PMCID: PMC2730754, DOI: 10.1016/j.ajog.2007.03.031.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virusIntrauterine contraceptive devicePelvic inflammatory diseaseHormonal contraceptionImmunodeficiency virusInflammatory diseasesDisease progressionContraceptive deviceRapid HIV disease progressionHIV disease progressionClinical disease progressionUrgent further studyCopper intrauterine contraceptive deviceContraceptionWomenFurther studiesDiseaseProgressionVirusPostpartumTrials
1998
Serum Retinol and HIV-1 RNA Viral Load in Rapid and Slow Progressors
Camp W, Allen S, Alvarez J, Jolly P, Weiss H, Phillips J, Karita E, Serufilira A, Vermund S. Serum Retinol and HIV-1 RNA Viral Load in Rapid and Slow Progressors. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1998, 18: 401-406. PMID: 9704954, DOI: 10.1097/00042560-199808010-00022.Peer-Reviewed Original ResearchMeSH KeywordsAdultDisease ProgressionFemaleHIV InfectionsHIV-1HumansRNA, ViralRwandaSurvival AnalysisTime FactorsViral LoadVitamin AVitamin A DeficiencyConceptsSerum retinol levelsHIV-1 RNA viral loadLow viral loadLow serum retinol levelsRNA viral loadSlow progressorsRetinol levelsViral loadHIV serologySerum retinolDisease progressionFirst HIV-positive testHigher serum retinol levelsAsymptomatic HIV infectionHigh HIV loadLow serum retinolSerum retinol valuesHIV disease progressionHIV-positive testHigh viral loadThirty HIVHIV loadHIV infectionRapid progressorsSerum vitaminSerum Retinol and HIV-1 RNA Viral Load in Rapid and Slow Progressors
Camp W, Allen S, Alvarez J, Jolly P, Weiss H, Phillips J, Karita E, Serufilira A, Vermund S. Serum Retinol and HIV-1 RNA Viral Load in Rapid and Slow Progressors. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1998, 18: 21-26. PMID: 9593454, DOI: 10.1097/00042560-199805010-00004.Peer-Reviewed Original ResearchMeSH KeywordsAdultDisease ProgressionFemaleHIV InfectionsHIV-1HumansRNA, ViralRwandaSurvival AnalysisTime FactorsViral LoadVitamin AVitamin A DeficiencyConceptsSerum retinol levelsLow viral loadHIV-1 RNA viral loadLow serum retinol levelsRNA viral loadSlow progressorsRetinol levelsViral loadHIV serologySerum retinolDisease progressionFirst HIV-positive testHigher serum retinol levelsAsymptomatic HIV infectionHigh HIV loadLow serum retinolSerum retinol valuesHIV disease progressionHIV-positive testHigh viral loadThirty HIVHIV loadHIV infectionRapid progressorsSerum vitaminThe REACH Project of the Adolescent Medicine HIV/AIDS Research Network: Design, Methods, and Selected Characteristics of Participants
Rogers A, Futterman D, Moscicki A, Wilson C, Ellenberg J, Vermund S. The REACH Project of the Adolescent Medicine HIV/AIDS Research Network: Design, Methods, and Selected Characteristics of Participants. Journal Of Adolescent Health 1998, 22: 300-311. PMID: 9561462, DOI: 10.1016/s1054-139x(97)00279-6.Peer-Reviewed Original ResearchMeSH KeywordsAcquired Immunodeficiency SyndromeAdolescentAdolescent Health ServicesCohort StudiesComorbidityData CollectionDisease ProgressionFemaleHealth Planning OrganizationsHIV InfectionsHumansMaleMulticenter Studies as TopicProgram DevelopmentProspective StudiesResearchResearch DesignUnited StatesConceptsAdolescent Medicine HIV/AIDS Research NetworkMedical chart abstractionGroup of HIVHIV-negative controlsAIDS Research NetworkHIV-positive youthLocal institutional review boardInstitutional review boardResearch NetworkREACH projectChart abstractionClinical characteristicsImmunologic profileClinical courseHIV pathogenesisPhysical examinationHIV epidemicStudy populationAdolescent careDisease comorbiditiesClinical experienceMultidisciplinary teamHormonal variationsStudy aimReview board